BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35623551)

  • 1. Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts.
    Ke Q; Wang Z; Huang X; Li L; Wu W; Qiu L; Jiao Y; Xie Y; Peng X; Liu J; Guo W
    Ann Hepatol; 2022; 27(5):100725. PubMed ID: 35623551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory hepatic encephalopathy induced by spontaneous portosystemic shunt: Selective splenic vein embolization versus shunt embolization.
    Zhang L; Wei B; Wang Z; Tong H; Wu H
    Dig Liver Dis; 2023 Mar; 55(3):381-386. PubMed ID: 36175324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
    Álvarez-López P; Campos-Varela I; Quiroga S; Díez I; Charco R; Simón-Talero M; Castells L
    Ann Hepatol; 2022; 27(3):100687. PubMed ID: 35192963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
    Lynn AM; Singh S; Congly SE; Khemani D; Johnson DH; Wiesner RH; Kamath PS; Andrews JC; Leise MD
    Liver Transpl; 2016 Jun; 22(6):723-31. PubMed ID: 26970243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy.
    Sakurabayashi S; Sezai S; Yamamoto Y; Hirano M; Oka H
    Cardiovasc Intervent Radiol; 1997; 20(2):120-4. PubMed ID: 9030502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Philips CA; Rajesh S; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2020 Aug; 39(4):377-387. PubMed ID: 32929684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shunt-preserving disconnection of the portal to systemic circulation in patients with hepatic encephalopathy.
    Ikeda O; Inoue S; Tamura Y; Yamashita YI; Baba H; Inomata Y; Yamashita Y
    Acta Radiol; 2018 Apr; 59(4):441-447. PubMed ID: 28791885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt.
    Rogal SS; Hu A; Bandi R; Shaikh O
    World J Gastroenterol; 2014 Jul; 20(25):8288-91. PubMed ID: 25009405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy.
    Laleman W; Simon-Talero M; Maleux G; Perez M; Ameloot K; Soriano G; Villalba J; Garcia-Pagan JC; Barrufet M; Jalan R; Brookes J; Thalassinos E; Burroughs AK; Cordoba J; Nevens F;
    Hepatology; 2013 Jun; 57(6):2448-57. PubMed ID: 23401201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A; Chalamarla LK; Singla N; Shasthry SM; Sarin SK
    Eur Radiol; 2020 Jun; 30(6):3462-3472. PubMed ID: 32048037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis.
    Yi F; Guo X; Wang L; Xu X; An Y; Tang Y; Zhang W; Tacke F; Arora A; Qi X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1694-1702. PubMed ID: 33393106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.
    Philips CA; Kumar L; Augustine P
    Indian J Gastroenterol; 2017 Sep; 36(5):411-419. PubMed ID: 29124669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of interventional embolization in cirrhotic patients with refractory hepatic encephalopathy associated with spontaneous portosystemic shunts.
    Ke Q; He J; Cai L; Lei X; Huang X; Li L; Liu J; Guo W
    Sci Rep; 2024 Jun; 14(1):14848. PubMed ID: 38937539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective embolization of the splenic vein in patients with hepatic encephalopathy and splenorenal shunt.
    Mezawa S; Homma H; Akiyama T; Katsuki S; Murakami K; Hirata K; Kogawa K; Takahashi S; Sato T; Doi T; Niitsu Y
    J Vasc Interv Radiol; 2004 Dec; 15(12):1475-81. PubMed ID: 15590808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doppler hemodynamic study in portal hypertension and hepatic encephalopathy.
    Perisic M; Ilic-Mostic T; Stojkovic M; Culafic D; Sarenac R
    Hepatogastroenterology; 2005; 52(61):156-60. PubMed ID: 15783018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatic encephalopathy due to spontaneous splenorenal shunt: successful treatment by transhepatic shunt embolization.
    Vavasseur D; Duvoux C; Cherqui D; Derhy S; Rahmouni A; Dhumeaux D; Mathieu D
    Cardiovasc Intervent Radiol; 1994; 17(5):298-300. PubMed ID: 7820841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-TIPS hepatic encephalopathy treated by occlusion balloon-assisted retrograde embolization of a coexisting spontaneous splenorenal shunt.
    Shioyama Y; Matsueda K; Horihata K; Kimura M; Nishida N; Kishi K; Terada M; Sato M; Yamada R
    Cardiovasc Intervent Radiol; 1996; 19(1):53-5. PubMed ID: 8653749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.